Racivir is a reverse transcriptase inhibitor. Racivir is anabolized to the active 5'-triphosphate in cells. HBV replication is equally inhibited in cultures incubated with Racivir when the compound is added 24 h preinfection, at infection, or 24 h postinfection. Racivir inhibits HBV replication by 50% at less than 20 nM in human hepatocytes.

143491-54-7

C8H10FN3O3S

247.25

(±)-FTC;PSI5004;RCV;PSI-5004;Racivir

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years